The Science of Childhood Cancer

A 15-week virtual lecture series

Developmental programs contribute to chemoresistance in pediatric solid tumors

Original lecture date: November 14, 2024

Michael Dyer, PhD

Chair, Developmental Neurobiology Department
Co-Leader, Developmental Biology & Solid Tumor Program
Richard C. Shadyac Endowed Chair in Pediatric Cancer Research
Investigator, Howard Hughes Medical Institute

Other lectures in the Spring 2025 series

Looking back and looking forward for the Children’s Oncology Group
Precision survivorship: predicting primary ovarian insufficiency risk in female survivors of childhood cancer
The leukemic niche - endothelial and macrophage control of clonality
Developing new models and therapies for high-risk pediatric embryonal brain tumors
Transcriptional dependencies in cancer
Chromatin-based regulations of gene transcription and oncogenesis
Lineage-specific dependencies in paediatric-type diffuse high-grade glioma
The ZERO Childhood Cancer - a national pediatric cancer precision medicine program
Transforming global pediatric cancer care: an update on strategies to address global inequities in childhood cancer care and control
Cardiometabolic risk factors in survivorship: a target to reduce morbidity and mortality

Comprehensive Cancer Center

St. Jude is the first and only National Cancer Institute-designated Comprehensive Cancer Center devoted solely to children

Explore the center